Biotricity, Inc. (BTCY)

Model N Income Statement

Financials in millions USD. Fiscal year is April - March.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021
Revenue	13.79	12.06	9.64	7.65	3.38
Revenue Growth (YoY)	14.32%	25.15%	26.00%	126.02%	138.75%
Cost of Revenue	3.23	3.71	4.2	3.08	2.11
Gross Profit	10.56	8.36	5.44	4.57	1.27
Selling, General & Admin	10.86	14.61	17.62	18.56	11.93
Research & Development	2.16	2.57	3.23	2.74	2.06
Operating Expenses	13.01	17.18	20.85	21.31	13.98
Operating Income	-2.45	-8.83	-15.41	-16.74	-12.71
Interest Expense	-5.2	-5.19	-2.58	-6.08	-2.79
Other Non Operating Income (Expenses)	-0.38	-0.03	-0.59	-0.67	0.45
EBT Excluding Unusual Items	-8.03	-14.05	-18.59	-23.49	-15.05
Other Unusual Items	-0.39	-0.04	-0.07	-5.64	-0.44
Pretax Income	-8.42	-14.09	-18.66	-29.13	-15.49
Net Income	-8.42	-14.09	-18.66	-29.13	-15.49
Preferred Dividends & Other Adjustments	3.52	0.83	0.88	1.09	0.96
Net Income to Common	-11.94	-14.93	-19.53	-30.22	-16.45
Shares Outstanding (Basic)	22	9	9	8	6
Shares Outstanding (Diluted)	22	9	9	8	6
Shares Change (YoY)	139.38%	3.83%	14.32%	21.13%	4.36%
EPS (Basic)	-0.55	-1.66	-2.26	-3.99	-2.63
EPS (Diluted)	-0.56	-1.66	-2.26	-3.99	-2.63
Free Cash Flow	-2.38	-6.69	-13.55	-15.19	-11.08
Free Cash Flow Per Share	-0.11	-0.74	-1.56	-2.01	-1.77
Gross Margin	76.61%	69.27%	56.46%	59.74%	37.60%
Operating Margin	-17.76%	-73.18%	-159.87%	-218.77%	-375.56%
Profit Margin	-86.60%	-123.75%	-202.65%	-395.01%	-486.10%
Free Cash Flow Margin	-17.26%	-55.49%	-140.55%	-198.60%	-327.37%
EBITDA	-2.44	-8.82	-15.4	-16.73	-
EBITDA Margin	-17.71%	-73.13%	-159.81%	-218.74%	-
D&A For EBITDA	0.01	0.01	0.01	0	-
EBIT	-2.45	-8.83	-15.41	-16.74	-12.71
EBIT Margin	-17.76%	-73.18%	-159.87%	-218.77%	-

Updated Feb 20, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.